New Enterprise Associates
VC Fund
Menlo Park, United States
New Enterprise Associates is a VC fund in Menlo Park focused on Software and Health Care. New Enterprise Associates offers capital and operational support to businesses throughout various development stages, ranging from initial seed rounds to public offerings. Its investment focus includes diverse industries such as software, consumer technology, medical devices, and biopharmaceuticals. The firm works alongside founders to address technical challenges and navigate changing economic environments. Beyond funding, the entity delivers domain expertise and functions as a collaborator for product development and market expansion.
- Total investments:
- 2102
- Last investment:
- Lead investor:
- 39%
- Fund size:
- $468M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries New Enterprise Associates invests in
Stages New Enterprise Associates invests in
Countries New Enterprise Associates invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 51 contacts → | |||
Round size
- Series A
- $6M–$55M
- Series B
- $10M–$85M
- Series C
- $15M–$100M
Investment Focus
Industry
- Software 270 (13%)
- Health Care 204 (10%)
- Biotechnology 163 (8%)
- Artificial Intelligence 122 (6%)
- Information Technology 109 (5%)
Stage
- Series A 369 (18%)
- Series B 362 (17%)
- Series C 251 (12%)
- Seed 208 (10%)
- Series D 132 (6%)
Country
- United States 839 (40%)
- China 22 (1%)
- India 19 (1%)
- United Kingdom 16 (1%)
- Canada 14 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Albert Graf
Venture Partner
|
Venture Partner | Total investments: 11 | Find email | |
Alex Sharata
Associate
|
Associate | Total investments: 2 | Find email | |
Anthony Florence
General Partner
|
General Partner | Total investments: 61 | Find email | |
Bala Deshpande
Sr. Managing Director, India
|
Sr. Managing Director, India | Total investments: 7 | Find email | |
Hilarie Koplow-McAdams
Venture Partner
|
Venture Partner | Total investments: 14 | Find email | |
| See all 51 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Spiko is a tokenization platform that offers to be the supplier of tokenized Money Market Funds. | $90M / Series B / Oct 06, 2026 | ||
| Namespace accelerates the development workflow of fast-moving software engineering teams. | $42M / Series B / Oct 05, 2026 | ||
| Clockwork Systems is a technology company that offers network-software solutions designed for high-performance, time-sensitive workloads, such as AI training, financial trading, online gaming, and distributed systems. The company's core product, FleetIQ, provides real-time fleet-level workload monitoring, traffic flow classification,congestion mitigation, and resilience to link and NIC failures. Its time-synchronization technology delivers nanosecond accuracy across large clusters, enabling systems to remain highly coordinated and reliable.The company's solution runs on standard commodity network interface cards (NICs) and Ethernet switches and supports deployment across public clouds, on-premises data centers, or hybrid environments. It supports customers by offering visibility into connectivity, latency, path quality, and job-level metrics, helping reduce failures and improve GPU utilization. | $31M / Venture - Series Unknown / Oct 05, 2026 | ||
| Basalt Health is a healthcare technology company that provides an AI-powered assistant for clinical teams. Its platform integrates with electronic medical records (EMRs), including major systems like Athena, and generates chart summaries, screening recommendations, specialist referrals, and verification workflows to reduce manual documentation burdens. The company focuses on enhancing the efficiency of patient-encounter preparation, enabling care teams to shift their focus from data entry to patient care, while employing HIPAA-compliant encryption and SOC 2 Type II standards for data security. | $20M / Series A / Sep 24, 2026 | ||
| Factory functions within integrated development environments, command line interfaces, and continuous integration pipelines. The technology allows for the delegation of technical tasks, including code refactors, system migrations, and incident responses. These digital agents also perform automated code reviews and facilitate the maintenance of builds during the development process. Integration extends to communication platforms and project management software, allowing users to trigger actions from various interfaces. The system supports the parallelization of agents to manage software updates and maintenance across multiple operating systems. | $200M / Venture - Series Unknown / Sep 15, 2026 | ||
| LLM Inference Hardware | $500M / Series C / Sep 10, 2026 | ||
| Latitude is working on a global payments system that links stablecoin-based settlement with local currency payout systems. | $35M / Series A / Sep 09, 2026 | ||
CaMaRa
|
CaMaRa is a biotechnology company developing new medicines for cardiometabolic conditions, including obesity, diabetes and kidney disease. | Seed / Sep 09, 2026 | |
| Tectora Therapeutics develops oral medicines designed to treat immune-mediated diseases, specifically focusing on immunology and inflammation. The company co-develops its pipeline by utilizing advanced computational drug discovery platforms and preclinical capabilities. Its core value proposition centers on translating clinically validated biologyinto oral small-molecule therapies to address significant unmet patient needs. | $55M / Series A / Sep 09, 2026 | ||
| Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivovalidation in diseased tissue has uncovered new approaches to target key compartments of the immune system.The company was incorporated in 2015 and is based in Newton, Massachusetts. | $66M / Series D / Aug 18, 2026 | ||
| See all 2102 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does New Enterprise Associates invest in?
New Enterprise Associates invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 2,102 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does New Enterprise Associates invest in?
New Enterprise Associates typically joins rounds of $6M–$55M at Series A, $10M–$85M at Series B and $15M–$100M at Series C. These are whole funding-round sizes, not New Enterprise Associates's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds New Enterprise Associates took part in.
How do I contact New Enterprise Associates?
Public channels for New Enterprise Associates include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at New Enterprise Associates?
The team at New Enterprise Associates includes Albert Graf (Venture Partner), Alex Sharata (Associate) and Anthony Florence (General Partner), among 51 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
